IRIS
BAGALONI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.637
EU - Europa 900
AS - Asia 640
SA - Sud America 79
AF - Africa 18
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.602
CN - Cina 254
IT - Italia 210
SG - Singapore 209
GB - Regno Unito 141
RU - Federazione Russa 132
UA - Ucraina 106
SE - Svezia 90
BR - Brasile 60
FR - Francia 59
TR - Turchia 56
DE - Germania 55
VN - Vietnam 47
FI - Finlandia 32
IE - Irlanda 27
MX - Messico 15
CA - Canada 14
IN - India 13
ES - Italia 11
HK - Hong Kong 11
AU - Australia 10
AR - Argentina 8
JP - Giappone 8
PL - Polonia 8
ZA - Sudafrica 8
NL - Olanda 7
IQ - Iraq 6
KR - Corea 6
BD - Bangladesh 5
BE - Belgio 4
EG - Egitto 4
IR - Iran 4
LT - Lituania 4
AT - Austria 3
EC - Ecuador 3
ID - Indonesia 3
LK - Sri Lanka 3
MA - Marocco 3
BH - Bahrain 2
EU - Europa 2
GD - Grenada 2
MD - Moldavia 2
PK - Pakistan 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.288
Salva come PNG Salva come JPEG
Città #
Ashburn 229
Fairfield 173
Woodbridge 141
Singapore 135
Southend 109
Houston 94
Cambridge 83
Ann Arbor 82
Seattle 77
Jacksonville 75
Wilmington 63
San Jose 58
Beijing 47
Chandler 46
New York 44
Dallas 36
Nanjing 35
Urbino 30
Izmir 29
Boardman 28
Los Angeles 24
Dublin 22
Ho Chi Minh City 18
Lauterbourg 17
Helsinki 16
Bremen 15
Düsseldorf 15
Princeton 15
Hebei 14
Dearborn 12
Moscow 12
Hong Kong 11
Milan 11
San Francisco 11
Tianjin 11
Chicago 10
Santa Clara 10
Shenyang 10
Brooklyn 9
San Diego 9
São Paulo 9
Changsha 8
Frankfurt am Main 8
Guangzhou 8
Hanoi 8
Istanbul 8
Redwood City 8
Rome 8
Vittuone 8
Jiaxing 7
Jinan 7
Johannesburg 7
Kocaeli 7
London 7
Pontedera 7
Sydney 7
Tokyo 7
Atlanta 6
Bisceglie 6
Boston 6
Denver 6
Nanchang 6
Nuremberg 6
Toronto 6
Cagliari 5
Montreal 5
Poplar 5
Rimini 5
The Dalles 5
Ankara 4
Brussels 4
Kunming 4
Lappeenranta 4
Leawood 4
Menlo Park 4
Mexico City 4
Portland 4
Querétaro 4
Redondo Beach 4
San Mateo 4
Seongnam 4
Turku 4
Warsaw 4
Augusta 3
Buffalo 3
Cairo 3
Canberra 3
Colombo 3
Des Moines 3
Elk Grove Village 3
Gurgaon 3
Lecce 3
Ningbo 3
Quito 3
Shanghai 3
Strasbourg 3
Sulaymaniyah 3
Acton 2
Ardabil 2
Barnala 2
Totale 2.186
Salva come PNG Salva come JPEG
Nome #
XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT 313
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. 294
Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. 259
DNA demethylating antineoplastic strategies: a comparative point of view. 256
Malten, a new synthetic molecule showing in vitro antiproliferative activity against tumor cells and induction of complex DNA structural alterations. 223
Sex-Related Differences in Impact On Safety Of Pharmacogenetic Profile For Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy 209
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with Ramucirumab-Paclitaxel or standard chemotherapy 209
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomized, phase III adjuvant TOSCA trial in high-risk colon cancer patients. 194
Patients treated with FOLFOX-4 or XELOX chemotherapy with high-risk stage II and III colon cancer (TOSCA trial): a different impact of pharmacogenetic profile on toxicity in women and men 172
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib 164
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with antiangiogenic or standard chemotherapy regimens 153
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES MAY AFFECT THE LOSS OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 142
A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy 141
Glycolytic competence in gastric adenocarcinomas negatively impacts on survival outcomes of patients treated with salvage paclitaxel-ramucirumab. 141
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma 130
Warburg effect and tp53 mutational status in gastric cancer patients under ramucirumab-based therapy 126
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES AFFECT THE DURATION OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 122
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy 103
Totale 3.351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 0 0 0 0 0 28 75 12
2021/2022281 33 15 13 63 9 14 9 32 15 10 22 46
2022/2023218 43 11 11 16 23 39 4 10 39 4 9 9
2023/2024147 13 10 4 11 12 44 4 8 0 20 4 17
2024/2025402 18 10 74 23 18 25 93 15 15 45 54 12
2025/2026858 120 70 89 192 84 83 72 31 64 53 0 0
Totale 3.351